Page last updated: 2024-11-04

ropinirole and Serotonin Syndrome

ropinirole has been researched along with Serotonin Syndrome in 2 studies

Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.

Research Excerpts

ExcerptRelevanceReference
"Two stroke patients were administered ropinirole (patient 1) and carbidopa/levodopa (patient 2) during rehabilitation."3.81Serotonin syndrome in stroke patients. ( Chang, MC; Jang, SH; Kwon, YM, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pagonabarraga, J1
Kulisevsky, J1
Jang, SH1
Kwon, YM1
Chang, MC1

Reviews

1 review available for ropinirole and Serotonin Syndrome

ArticleYear
[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?].
    Revista de neurologia, 2014, Jan-01, Volume: 58, Issue:1

    Topics: Amantadine; Antiparkinson Agents; Cardiovascular Diseases; Catechol O-Methyltransferase; Catechol O-

2014

Other Studies

1 other study available for ropinirole and Serotonin Syndrome

ArticleYear
Serotonin syndrome in stroke patients.
    Journal of rehabilitation medicine, 2015, Volume: 47, Issue:3

    Topics: Carbidopa; Dopamine Agonists; Drug Combinations; Humans; Indoles; Levodopa; Male; Middle Aged; Serot

2015